Newsroom press releases

06/05/25 - 17:41

Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)

Financial Data

Download

28/04/25 - 16:50

Shareholders' Meeting 2025 (138.81 KB)

Other

Download

18/04/25 - 18:11

Diasorin receives 510(k) clearance for its second multiplex molecular panel for diagnosing bloodstream infections on LIAISON PLEX® (161.29 KB)

Products

Download

07/04/25 - 13:07

Publication of the lists of candidates for the appointment of the Board Directors, the Board of Statutory Auditors and relevant proposals for resolution. (111.09 KB)

Financial Disclosures

Download

04/04/25 - 0:59

Notice pursuant to art. 144-octied, para. 2 of CONSOB regulation No. 1971/1999 (125.78 KB)

Other

Download

31/03/25 - 19:36

Adoption of the enhancement of the increased voting rights mechanism: withdrawal exercised by 1.69% of the share capital. Statutory option and pre-emption offer period to start on 31 March 2025. (119.78 KB)

Other

Download

18/03/25 - 11:54

Diasorin launches the Simplexa™ C. auris direct assay on the LIAISON® MDX instrument in all countries accepting the CE Mark (126.65 KB)

Products Molecular

Download

14/03/25 - 16:29

The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)

Financial Data

Download

03/03/25 - 21:19

Registration and publication the minutes of shareholders' meeting. Withdrawal right. (101.04 KB)

Other

Download

03/03/25 - 21:05

Notice to Shareholders - Information regarding the exercise of the withdrawal right (88.54 KB)

Other

Download

28/02/25 - 11:49

The Extraordinary Meeting of Shareholders approves the enhancement of the increased voting rights mechanism (111.6 KB)

Other

Download

27/01/25 - 20:14

Proposal to enhance the increased voting rights mechanism to support the Company's growth strategy, also by external lines, and reward a shareholder base with a long-term investment horizon (126.5 KB)

Other

Download

22/12/10 - 1:00

2011 Financial calendar (180.28 KB)

Financial Data

Download

20/12/10 - 1:00

Dividend may be distributed in June (445.78 KB)

Financial Data

Download

02/12/10 - 1:00

Comment on position Paper on Vitamin D (53.46 KB)

Products Immunodiagnostic

Download

24/11/10 - 1:00

Change in share capital (46.85 KB)

Financial Data

Download

18/11/10 - 1:00

Financial instruments to employees (48.33 KB)

Financial Data

Download

05/11/10 - 1:00

The BoD approves Q3'10 results (414.16 KB)

Financial Data

Download

02/11/10 - 1:00

Change in share capital (313.61 KB)

Financial Data

Download

08/10/10 - 2:00

2010 Financial calendar update (174.1 KB)

Financial Data

Download

30/09/10 - 2:00

Change in share capital (5.25 KB)

Financial Data

Download

24/09/10 - 2:00

Financial instruments to employees (48.81 KB)

Financial Data

Download

16/09/10 - 2:00

Stock options exercised by key managers (195.67 KB)

Financial Data

Download

02/09/10 - 2:00

Financial instruments to employees (24.27 KB)

Financial Data

Download

06/08/10 - 2:00

The BoD approves H1'10 results (287.11 KB)

Financial Data

Download

07/07/10 - 2:00

Agreement with Meridian Inc. (182.7 KB)

Acquisition / Partnership

Download

06/07/10 - 2:00

2010 Financial calendar update (174.1 KB)

Financial Data

Download

02/07/10 - 2:00

Financial instruments to employees (24.37 KB)

Financial Data

Download

01/06/10 - 2:00

Acquisition of MUREX product line (102.6 KB)

Acquisition / Partnership

Download

14/05/10 - 2:00

The BoD approves Q1'10 results (254.05 KB)

Financial Data

Download

27/04/10 - 2:00

Approval of statutory financial statements (182.99 KB)

Financial Data

Download

20/04/10 - 2:00

2010 Financial calendar update (168.23 KB)

Financial Data

Download

14/04/10 - 2:00

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)

Financial Data

Download

09/04/10 - 2:00

China approves new prenatal screening product line on LIAISON (141.08 KB)

Products Immunodiagnostic

Download

02/04/10 - 2:00

Financial instruments to employees (27.79 KB)

Financial Data

Download

22/03/10 - 1:00

The BoD approves FY 2009 results (306.02 KB)

Financial Data

Download

10/03/10 - 1:00

Acquisition of MUREX product line (45.5 KB)

Acquisition / Partnership

Download

01/03/10 - 1:00

2010 Financial calendar update (192.49 KB)

Financial Data

Download

12/02/10 - 1:00

The BoD approves Q4'09 results (213.8 KB)

Financial Data

Download

18/01/10 - 1:00

2010 Financial calendar (103 KB)

Financial Data

Download

Newsroom press releases

Select year

Newsroom press category

Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)

Shareholders' Meeting 2025 (138.81 KB)

Diasorin receives 510(k) clearance for its second multiplex molecular panel for diagnosing bloodstream infections on LIAISON PLEX® (161.29 KB)

Publication of the lists of candidates for the appointment of the Board Directors, the Board of Statutory Auditors and relevant proposals for resolution. (111.09 KB)

Notice pursuant to art. 144-octied, para. 2 of CONSOB regulation No. 1971/1999 (125.78 KB)

Adoption of the enhancement of the increased voting rights mechanism: withdrawal exercised by 1.69% of the share capital. Statutory option and pre-emption offer period to start on 31 March 2025. (119.78 KB)

Diasorin launches the Simplexa™ C. auris direct assay on the LIAISON® MDX instrument in all countries accepting the CE Mark (126.65 KB)

The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)

Registration and publication the minutes of shareholders' meeting. Withdrawal right. (101.04 KB)

Notice to Shareholders - Information regarding the exercise of the withdrawal right (88.54 KB)

The Extraordinary Meeting of Shareholders approves the enhancement of the increased voting rights mechanism (111.6 KB)

Proposal to enhance the increased voting rights mechanism to support the Company's growth strategy, also by external lines, and reward a shareholder base with a long-term investment horizon (126.5 KB)

2011 Financial calendar (180.28 KB)

Dividend may be distributed in June (445.78 KB)

Comment on position Paper on Vitamin D (53.46 KB)

Change in share capital (46.85 KB)

Financial instruments to employees (48.33 KB)

The BoD approves Q3'10 results (414.16 KB)

Change in share capital (313.61 KB)

2010 Financial calendar update (174.1 KB)

Change in share capital (5.25 KB)

Financial instruments to employees (48.81 KB)

Stock options exercised by key managers (195.67 KB)

Financial instruments to employees (24.27 KB)

The BoD approves H1'10 results (287.11 KB)

Agreement with Meridian Inc. (182.7 KB)

2010 Financial calendar update (174.1 KB)

Financial instruments to employees (24.37 KB)

Acquisition of MUREX product line (102.6 KB)

The BoD approves Q1'10 results (254.05 KB)

Approval of statutory financial statements (182.99 KB)

2010 Financial calendar update (168.23 KB)

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)

China approves new prenatal screening product line on LIAISON (141.08 KB)

Financial instruments to employees (27.79 KB)

The BoD approves FY 2009 results (306.02 KB)

Acquisition of MUREX product line (45.5 KB)

2010 Financial calendar update (192.49 KB)

The BoD approves Q4'09 results (213.8 KB)

2010 Financial calendar (103 KB)

Price Sensitive